In re Cornerstone Therapeutics: Dismissal under 102(b)(7) Unavailable to Independent Directors when Entire Fairness Applies | Practical Law
The Delaware Court of Chancery ruled in In re Cornerstone Therapeutics Stockholder Litigation that in a controlling-stockholder transaction in which the plaintiff pleads allegations of unfairness, any directors who facilitated the transaction, even if disinterested and independent, cannot obtain dismissal of the claims against them before the conclusion of the trial, even if they are indemnified under Section 102(b)(7).